Felix Pinkston
Sep 25, 2026 19:53
NVIDIA sits at $226.60 with a wall of institutional conviction behind it — 58 of 59 analysts screaming buy and a consensus target of ~$327. But with the stock trading near upper Bollinger territory…
NVIDIA at $226.60: The Bull Case Has Never Been Cheaper — and That’s the Problem
Strip away the noise and what you have in NVDA right now is arguably the most compelling fundamental backdrop in large-cap tech — sitting paradoxically at a valuation that feels almost embarrassingly cheap for what this company is delivering. Q2 FY2027 revenue came in at $96.2 billion, up 106% year-over-year. Data center revenue alone — the lifeblood of this AI infrastructure supercycle — jumped 117% to $89 billion. These aren’t estimates or projections. These are delivered numbers that annihilated consensus, extending what is now a five-consecutive-quarter streak of earnings beats.
Yet NVDA trades at a trailing P/E of roughly 28x and a forward P/E of ~24x. Let that sink in for a second. A company growing revenue at 83%+ and earnings at 124% — with gross margins at 74.67% and operating margins at 65.21% — is priced cheaper than the broader technology sector average of ~79x P/E. The discount is historic. Bloomberg data confirms NVDA’s forward multiple is at its lowest point in over a decade relative to its own growth trajectory. The $80 billion share buyback authorization with $99 billion still remaining as of Q2 FY2027 signals that Jensen Huang’s team isn’t sweating the macro environment — they’re buying the dip themselves.
That’s the fundamental setup as covered by Blockchain.news: a generational AI compounder priced like a cyclical semiconductor play. The market is either gifting a second chance or pricing in a structural air pocket that most traders aren’t fully pricing in yet.
The Technical Structure Says: Buyers Are In Control, But the Door Is Narrow
NVDA opened September 25 at $226.60, up 1.6% on the session, sitting cleanly above every major moving average on the daily chart. The SMA 7 at $225.27, SMA 20 at $222.11, and SMA 50 at $221.72 are stacked in bullish sequence below price — a textbook trending structure that short sellers have been grinding their teeth against for weeks.
The momentum profile, however, tells a more nuanced story. The MACD histogram has converged to flat zero — not bearish by any means, but signaling that the explosive leg of the recent upswing has plateaued. The RSI at 56.89 sits comfortably in neutral-to-bullish territory with room to push toward the 65-70 overbought zone before triggering any meaningful mean-reversion signal. The Stochastic %K at 83.09 is a flag worth watching — when it crosses back below %D (currently 66.47) from these elevated levels, it’s historically preceded short-term pullbacks of $4-$8 in NVDA’s recent price behavior.
The Bollinger Band setup reinforces the tension. At a %B of 0.70, price is in the upper third of the band but not yet stretched to the boundary at $233.32. There is room to run, but not unlimited room. Immediate resistance at $228.40 is the first real test, with the stronger structural wall at $230.21. A decisive daily close above $230.21 — on volume — would be the green light institutions have been waiting to see before committing fresh capital at these levels.
On the derivatives side, the picture is unambiguous: the long/short ratio sits at 1.43 globally with top traders even more aggressive at 1.54 long. The taker buy/sell ratio of 1.16 reflects active accumulation, not passive drift. Positive funding at 0.018% confirms longs are paying a premium to hold their positions — not a crowded extreme, but enough to suggest the path of least resistance remains upward while support holds.
Wall Street’s $327 Target: The Valuation Case Is Iron-Clad, the Timing Is the Variable
Of 59 analysts covering NVDA, 58 are constructive. The mean consensus price target sits at approximately $327-$328, implying ~44% upside from current levels. The high target of $515 belongs to the most aggressive bulls; even the low target of $180 from the lone bear is, at this point, looking increasingly like a career risk. Goldman Sachs maintained a Buy with a $300 target as recently as September 10 — and that was before the company confirmed Q3 FY2027 guidance of $108 billion in revenue, which would represent yet another quarter of triple-digit year-over-year growth.
The Zacks FY2027 earnings consensus sits at $9.25 per share, implying 93.9% earnings growth versus FY2026’s $4.77. FY2028 consensus climbs further to $15.33 — a company growing EPS by another 65.8% the year after. At $226.60, you’re paying roughly 14.8x FY2028 earnings. That’s the kind of multiple that typically applies to slow-growth industrials, not the undisputed monopoly infrastructure supplier to every major AI model being trained on the planet today.
As Blockchain.news has tracked throughout this AI infrastructure cycle, NVIDIA’s strategic positioning as the supplier to every side of the AI race — supporting OpenAI, Anthropic, and even SpaceXAI’s Grok 4.7 simultaneously — insulates it from the winner-take-all risk that haunts individual AI application companies. Jensen Huang isn’t betting on who wins the model wars. He’s selling every fighter their weapons.
The net margin of 63.66% and return on equity of 96.04% are not flukes of accounting. They reflect a structural moat around CUDA-based accelerated computing that competitors have spent years and billions of dollars trying to crack — without meaningful success at scale. The $23.59 billion in annual R&D spend simultaneously widens the technical gap while its ratio to revenue shrinks, a sign of maturing operational leverage that most analysts are only beginning to model correctly.
Price Scenarios for the Next 7-30 Days: Pick a Side
Bull Case (60% probability): NVDA holds the $223.10 immediate support zone and pushes through $228.40 resistance within the next 3-5 sessions. A confirmed close above $230.21 with taker buy ratios remaining above 1.10 opens the door to a direct run toward the upper Bollinger band at $233.32, and then the 52-week high at $236.54. The 30-day bull target is $240-$245, where the stock would still trade at only ~26x FY2027 earnings — far from stretched. Entry on any intraday pullback into the $224-$225 range carries favorable risk/reward. Stop-loss: daily close below $219.61 (strong support), risking roughly 3% to target a potential 8-9% gain.
Bear Case (40% probability): The MACD convergence to zero and Stochastic %K rollover from 83 trigger a reflexive pullback. NVDA loses $223.10 on a closing basis, and the broader market softens ahead of the November 17 earnings date, allowing profit-takers to drag the stock back toward the $219-$221 confluence zone where the SMA 50 and strong support converge. This is not a thesis-breaking move — it’s a consolidation. For swing traders, a break back through $222 on elevated sell volume is the cue to reduce or hedge. The downside target in this scenario is $216-$218, coinciding with the lowest analyst price target in the current coverage universe. Any dip into that zone should be treated as an aggressive accumulation opportunity, not a panic exit.
The November 17 earnings catalyst is the event risk anchoring both scenarios. The AI capex cycle from hyperscalers — Microsoft, Amazon, Google, and Meta — is showing zero signs of deceleration, and NVDA’s $108 billion Q3 guidance de-risks the near-term fundamental story considerably. The only credible bear argument right now is valuation relative to the broader rate environment, and even that thesis struggles when the forward P/E is sitting near decade lows. As tracked and reported by Blockchain.news, the tokenized trading environment on Binance reflects continuous institutional price discovery outside traditional Wall Street hours — the sustained long bias and positive funding rate confirm that informed money is not positioning for a structural breakdown.
Manage the entry, respect the $219.61 stop, and let the fundamentals do the heavy lifting into year-end.
Fundamental data, analyst ratings and price targets are sourced from Yahoo Finance as of September 25, 2026 and reflect consensus estimates, not investment advice.
Image source: Shutterstock
Be the first to comment